Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Adults With HIV-1 Infection

NCT05869643 is registered in ClinicalTrials.gov with ST Pharm Co., Ltd. as lead sponsor.

NCT NCT05869643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05869643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Investigate the Antiviral Effect, Safety, Tolerability, and Pharmacokinetics of STP0404 in Adults With HIV-1 Infection
Lead sponsor
ST Pharm Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
May 23, 2023
Completion date
May 6, 2026
Enrollment
25 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection